Report: GSK recalls blood-pressure drug made at Novartis plant

NEW YORK — GlaxoSmithKline has recalled nearly 400,000 bottles of a hypertension drug that were distributed in the United States, according to published reports.

Reuters Health reported that GSK was recalling 394,230 bottles of its DynaCirc CR after the drug's manufacturer, Novartis, reported inconsistent packaging practices. The generic drug is manufactured at a Novartis plant in Lincoln, Neb.

No adverse events were reported, GSK was quoted as saying, but the drug maker elected to put forth a recall as a precautionary measure.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

Recommended stories

Login or Register to post a comment.